Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.

Becher, R

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma. [electronic resource] - British journal of cancer Jun 1989 - 948 p. digital

Publication Type: Journal Article

0007-0920

10.1038/bjc.1989.201 doi


Antineoplastic Agents--administration & dosage
Drug Evaluation
Humans
Medroxyprogesterone--administration & dosage
Medroxyprogesterone Acetate
Melanoma--drug therapy